If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Retevmo ® (selpercatinib) tablets
40 mg, 80 mg, 120 mg, 160 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How are Retevmo® (selpercatinib) tablets supplied?
In the second half of 2024, Retevmo® (selpercatinib) will be supplied as film-coated tablets in strengths of 40 mg, 80 mg, 120 mg, and 160 mg.
Selpercatinib Tablet Supply
Selpercatinib tablets will be available in 40 mg, 80 mg, 120 mg, and 160 mg dosage strengths.1
Selpercatinib Tablet Supply provides a description of how selpercatinib tablets are supplied.
Tablet Strength |
Description |
Package Configuration |
NDC Number |
40 mg |
Light gray, film coated, round tablets debossed with “Ret 40” on one side and “5340” on the other side |
60 count bottle |
NDC 0002-5340-60 |
80 mg |
Dark red-purple, film coated, round tablets |
60 count bottle |
NDC 0002-6082-60 |
120 mg |
Light purple, film coated, round tablets debossed with “Ret 120” on one side and “6120” on the other side |
60 count bottle |
NDC 0002-6120-60 |
160 mg |
Light pink, film coated, round tablets debossed with Ret “160” on one side and “5562” on the other side |
60 count bottle |
NDC 0002-5562-60 |
Abbreviation: NDC = national drug code
Enclosed Prescribing Information
Reference
1Retevmo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2024.
Date of Last Review: April 05, 2024